Learn more about investing in Mendel

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.

Mendel is a hybrid intelligent engine (human/AI) that can collect a patient’s medical records and combine it with the genetic profile of his or her cancer to find personalized meds that are still in the trial phase. It can also pair a patient with oncologists with a track record matching the patient’s case for a second opinion. Mendel’s business model is free for patients, including the 56% of cancer patients outside the U.S. and Europe.